Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice

Science Translational Medicine

Volumn 5, Issue 168, 2013, Pages

  Zheng, Jian ^a   Liu, Yinping ^a   Liu, Yuan ^a   Liu, Ming ^b   Xiang, Zheng ^a   Lam, Kwok Tai ^a   Lewis, David B ^c   Lau, Yu Lung ^a   Tu, Wenwei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CD3 ANTIGEN; CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL THERAPY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ACUTE DISEASE; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ACUTE DISEASE; ANIMALS; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINES; CTLA-4 ANTIGEN; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNITY; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 84872545656     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004943     Document Type: Article

References (39)

1. V. T. Ho, R. J. Soiffer, The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98, 3192-3204 (2001).
2. M. Siadak, K. M. Sullivan, The management of chronic graft-versus-host disease. Blood Rev. 8, 154-160 (1994).
3. S. Sakaguchi, T. Yamaguchi, T. Nomura, M. Ono, Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008). (Pubitemid 351707693)
4. E. M. Shevach, From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006). (Pubitemid 44224153)
5. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9, 1144-1150 (2003). (Pubitemid 37173698)
6. K. L. Hippen, S. C. Merkel, D. K. Schirm, C. Nelson, N. C. Tennis, J. L. Riley, C. H. June, J. S. Miller, J. E. Wagner, B. R. Blazar, Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transplant. 11, 1148-1157 (2011).
7. + regulatory T cell function. Science 322, 271-275 (2008).
8. + suppressor T cells. Nat. Immunol. 5, 469-471 (2004).
9. - T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev. 182, 201-206 (2001). (Pubitemid 33070219)
10. + T suppressor cells are back to the game: Are they players in autoimmunity? Autoimmun. Rev. 1, 279-283 (2002). (Pubitemid 38352570)
11. + Treg-mediated suppression. Trends Immunol. 29, 337-342 (2008).
12. + suppressor T cells are back in the game. J. Clin. Invest. 120, 3432-3434 (2010).
13. + regulatory T cells. Am. J. Transplant. 12, 2335-2347 (2012).
14. + T cells treated with anti-CD3 antibody requires TNF. Eur. J. Immunol. 40, 2891-2901 (2010).
15. + Tregs. J. Clin. Invest. 115, 2904-2913 (2005). (Pubitemid 41434418)
16. + regulatory T cells that suppress allo-reactive memory T cells. Eur. J. Immunol. 41, 1663-1674 (2011).
17. M. Gilliet, Y. J. Liu, Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704 (2002). (Pubitemid 34259715)
18. S. Jiang, S. Tugulea, G. Pennesi, Z. Liu, A. Mulder, S. Lederman, P. Harris, R. Cortesini, N. Suciu-Foca, Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59, 690-699 (1998). (Pubitemid 28467718)
19. + regulatory T cells in vitro. Transplantation 83, 1098-1106 (2007). (Pubitemid 46659122)
20. + regulatory T cells from naive precursors by CD40-activated B cells. Blood 112, 2554-2562 (2008).
21. + regulatory T cells. Cell. Mol. Immunol. 7, 44-50 (2010).
22. + T cells by an intrinsic IFN-γ-and T-bet-dependent pathway. Eur. J. Immunol. 41, 128-139 (2011).
23. J. Zheng, Y. Liu, G. Qin, P. L. Chan, H. Mao, K. T. Lam, D. B. Lewis, Y. L. Lau, W. Tu, Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J. Immunol. 183, 3742-3750 (2009).
24. F. Issa, J. Hester, R. Goto, S. N. Nadig, T. E. Goodacre, K. Wood, Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90, 1321-1327 (2010).
25. S. N. Nadig, J. Wieckiewicz, D. C. Wu, G. Warnecke, W. Zhang, S. Luo, A. Schiopu, D. P. Taggart, K. J. Wood, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med. 16, 809-813 (2010).
26. W. Tu, J. Zheng, Y. Liu, S. F. Sia, M. Liu, G. Qin, I. H. Ng, Z. Xiang, K. T. Lam, J. S. Peiris, Y. L. Lau, The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice. J. Exp. Med. 208, 1511-1522 (2011).
27. K. R. Cooke, L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte Jr., J. M. Crawford, J. L. Ferrara, An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88, 3230-3239 (1996). (Pubitemid 26357409)
28. W. Krenger, G. R. Hill, J. L. Ferrara, Cytokine cascades in acute graft-versus-host disease. Transplantation 64, 553-558 (1997). (Pubitemid 27377183)
29. J. L. Ferrara, R. Levy, N. J. Chao, Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol. Blood Marrow Transplant. 5, 347-356 (1999).
30. + regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J. Immunol. 189, 464-474 (2012).
31. + regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 119, 5898-5908 (2012).
32. X. L. Li, S. Ménoret, S. Bezie, L. Caron, D. Chabannes, M. Hill, F. Halary, M. Angin, M. Heslan, C. Usal, L. Liang, C. Guillonneau, B. Le Mauff, M. C. Cuturi, R. Josien, I. Anegon, Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance. J. Immunol. 185, 823-833 (2010).
33. D. H. Fowler, R. E. Gress, Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: Considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk. Lymphoma 38, 221-234 (2000). (Pubitemid 30303657)
34. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, T. Yamaguchi, Regulatory T cells: How do they suppress immune responses? Int. Immunol. 21, 1105-1111 (2009).
35. K. Wing, T. Yamaguchi, S. Sakaguchi, Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol. 32, 428-433 (2011).
36. T. R. Malek, I. Castro, Interleukin-2 receptor signaling: At the interface between tolerance and immunity. Immunity 33, 153-165 (2010).
37. + T cells in multiple sclerosis. J. Immunol. 176, 7119-7129 (2006). (Pubitemid 43787894)
38. K. Trandem, J. Zhao, E. Fleming, S. Perlman, Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 186, 3642-3652 (2011).
39. G. Qin, H. Mao, J. Zheng, S. F. Sia, Y. Liu, P. L. Chan, K. T. Lam, J. S. Peiris, Y. L. Lau, W. Tu, Phosphoantigen-expanded human γδ T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J. Infect. Dis. 200, 858-865 (2009).